Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic

  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about PHRRF

Recent news which mentions PHRRF

Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
Tickers ATAI CMND CMPS CYBN
Tags News Psychedelics Reform PMBHF
From Benzinga
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
Tickers ATAI CMPS CYBN DMTTF
Tags DMTTF ENVB Markets
From Benzinga
PharmaTher Is 'One Step Closer To Being A Ketamine Leader' Due To FDA Acceptance
Tickers PHRRF
Tags Ketamine Treatment Health Care Psychedelics
From Benzinga
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
Tickers ATAI CMPS CYBN JAZZ
Tags Research Nester Small Cap Psychedelics
From Benzinga
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
Tickers ATAI AWKNF CMND CMPS
Tags Psilocybin program GHRS Small Cap
From Benzinga
PharmaTher Aims To Mitigate Ketamine Shortage With New FDA Application
Tickers PHRRF
Tags PHRRF Market News Cannabis
From Benzinga
Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More
Tickers CLABF CMPS ENVB FLHLF
Tags Cannabis PSIL Market News
From Benzinga
PharmaTher's DMT Patch Shows Positive Outcomes, Investment Toward The Clinical Stage
Tickers PHRRF
Tags Markets Sairiyo Therapeutics Inc News
From Benzinga
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
Tickers BETRF CYBN DMTTF DSNKY
Tags FDA Psychedelics Financing Asset Sales
From Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
Tickers BETRF PHRRF
Tags News Guidance Markets
From Benzinga
Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets
Tickers FTHWF PHRRF
Tags FTHWF Psychedelics Ketamine Treatment
From Benzinga
PharmaTher's Novel Ketamine Heads For The US Market With New Collaboration Agreement
Tickers PHRRF
Tags News Markets Psychedelics
From Benzinga
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
Tickers CMND CMPS HUGE IWINF
Tags IWINF PLSH Cannabis
From Benzinga
Parkinson's Patients May Benefit From Ketamine, PharmaTher Applies For FDA Fast Track
Tickers PHRRF
Tags Parkinson's Disease Biotech PharmaTer
From Benzinga
Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
Tickers IGXT NUMIF PHRRF RVVTF
Tags IGXT News Psychedelics Reform
From Benzinga
MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update
Tickers PHRRF RVVTF
Tags Cannabis Market News PHRRF
From Benzinga
Ketamine Company Advances Parkinson's Treatment Through Final Stages Toward FDA Approval
Tickers PHRRF
Tags Legal News KETARX
From Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
Tickers AGNPF AWKNF CMND CYBN
Tags Markets Management CYBN
From Benzinga
Development Of DMT Transdermal Patch With Eye Disease Treatment In Mind
Tickers LMLLF PHRRF
Tags Markets LMLLF Ocular Diseases
From Benzinga
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
Tickers AWKNF NUMIF OPTHF PHRRF
Tags Psilocybin program MDMA treatment NUMIF
From Benzinga
PharmaTher Seeks Regulatory Approval Of New Ketamine Delivery System For Anesthesia And Sedation
Tickers PHRRF
Tags News FDA Drug Approval Management
From Benzinga
Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
Tickers IWINF ORIG PHRRF PSIL
Tags Benzinga MDMA/assisted therapy Psychedelics Investing
From Benzinga
MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
Tickers OPTHF PHRRF RVVTF
Tags Cannabis Psychedelics Investing PHRRF
From Benzinga
PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch
Tickers PHRRF RVVTF
Tags FDA Approval News MDMA Therapy
From Benzinga
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More
Tickers CLABF CMND CYBN FLHLF
Tags News MSSTF Earnings
From Benzinga
Search Is On For Psychedelic Patents & FDA Designations, 3 Companies Share News
Tickers MSSTF PHRRF
Tags News MSSTF Ketamine
From Benzinga
Psychedelics Market Could Reach $12B By 2029, Says New Report
Tickers CMPS PHRRF
Tags analyst report News Small Cap
From Benzinga
2 Psychedelics Companies Tout Advanced Clinical Trials, Progress With Key Products
Tickers GHRS PHRRF
Tags Guidance News Management
From Benzinga
FDA OKs Ketamine For Treating Organ Transplant Injuries With 'Orphan Drug' Status
Tickers PHRRF
Tags Orphan Drug Designation Markets Legal
From Benzinga
Ketamine Could Soon Be A Treatment Option For This Rare Genetic Neurological Disorder
Tickers PHRRF
Tags Neurological Disorders News Fabio Chianelli
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.